 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *sb0975*      
SENATE BILL 975  
J5   5lr2643  
    CF HB 1243  
By: Senator Lam  
Introduced and read first time: January 28, 2025  
Assigned to: Finance  
Committee Report: Favorable  with amendments  
Senate action: Adopted  
Read second time: March 10, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Health Insurance – Coverage for Specialty Drugs  2 
 
FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health 3 
maintenance organizations from excluding coverage for certain specialty drugs that 4 
are administered or dispensed by a provider that meets certain criteria; requiring 5 
the reimbursement rate for certain specialty drugs to meet certain criteria; and 6 
generally  relating to health insurance coverage for specialty drugs.  7 
 
BY repealing and reenacting, without amendments,  8 
 Article – Insurance  9 
Section 15 –847(a)(1) and (5)  10 
 Annotated Code of Maryland  11 
 (2017 Replacement Volume and 2024 Supplement)  12 
 
BY repealing and r eenacting, with amendments,  13 
 Article – Insurance  14 
Section 15 –847(d), 15 –1611.1, and 15 –1612  15 
 Annotated Code of Maryland  16 
 (2017 Replacement Volume and 2024 Supplement)  17 
 
BY adding to  18 
 Article – Insurance  19 
Section 15–847(h) and  15–847.2  20 
 Annotated Code of Maryland  21 
 (2017 Replacement Volume and 2024 Supplement)  22 
2 SENATE BILL 975   
 
  
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 1 
That the Laws of Maryland read as follows:  2 
 
Article – Insurance  3 
 
15–847. 4 
 
 (a) (1) In this section the following words have the meanings  indicated.  5 
 
  (5) (i) “Specialty drug” means a prescription drug that:  6 
 
    1. is prescribed for an individual with a complex or chronic 7 
medical condition or a rare medical condition;  8 
 
    2. costs $600 or more for up to a 30 –day supply;  9 
 
    3. is not ty pically stocked at retail pharmacies; and  10 
 
    4. A. requires a difficult or unusual process of delivery to 11 
the patient in the preparation, handling, storage, inventory, or distribution of the drug; or  12 
 
    B. requires enhanced patient education, management, or 13 
support, beyond those required for traditional dispensing, before or after administration of 14 
the drug.  15 
 
   (ii) “Specialty drug” does not include a prescription drug prescribed 16 
to treat diabetes, HIV, or AIDS.  17 
 
 (d) Subject to SUBSECTION (H) OF THIS SECTION AND  § 15–805 of this subtitle 18 
[and], notwithstanding § 15 –806 of this subtitle, [nothing in ] AND EXCEPT AS PROVID ED 19 
IN § 15–847.2  OF THIS SUBTITLE , this article or regulations adopted under this article 20 
[precludes ] DO NOT PRECLUDE  an entity subject to this section from requiring a covered 21 
specialty drug to be obtained through:  22 
 
  (1) a designated pharmacy or other source authorized under the Health 23 
Occupations Article to dispense or administer prescription drugs; or  24 
 
  (2) a pharma cy participating in the entity’s provider network, if the entity 25 
determines that the pharmacy:  26 
 
   (i) meets the entity’s performance standards; and  27 
 
   (ii) accepts the entity’s network reimbursement rates.  28 
 
 SENATE BILL 975  3 
 
  (H) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 1 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 2 
SPECIALTY DRUGS ADMI NISTERED TO PATIENTS  IN A SETTING REGULAT ED BY THE 3 
HEALTH SERVICES COST REVIEW COMMISSION . 4 
 
15–847.2.  5 
 
 (A) IN THIS SECTION , “SPECIALTY DRUG ” HAS THE MEAN ING STATED IN § 6 
15–847 OF THIS SUBTITLE . 7 
 
 (B) (1) THIS SECTION APPLIES TO: 8 
 
   (I) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 9 
PROVIDE COVERAGE FOR  PRESCRIPTION DRUGS U NDER INDIVIDUAL , GROUP , OR 10 
BLANKET HEALTH INSUR ANCE POLICIES OR CON TRACTS THAT ARE  ISSUED OR 11 
DELIVERED IN THE STATE ; AND 12 
 
   (II) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 13 
COVERAGE FOR PRESCRI PTION DRUGS UNDER IN DIVIDUAL OR GROUP CO NTRACTS 14 
THAT ARE ISSUED OR D ELIVERED IN THE STATE . 15 
 
  (2) AN INSURER , A NONPROFIT HEALTH S ERVICE PLAN , OR A HEALTH 16 
MAINTENANCE ORGANIZA TION THAT PROVIDES C OVERAGE FOR PRESCRIP TION 17 
DRUGS THROUGH A PHAR MACY BENEFITS MANAGE R IS SUBJECT TO THE 18 
REQUIREMENTS OF THIS  SECTION . 19 
 
 (C) AN ENTITY SUBJECT TO THIS SECTION MAY NOT  EXCLUDE COVERAGE 20 
FOR A COVERED SPECIA LTY  DRUG ADMINISTERED OR  DISPENSED BY A PROVI DER 21 
UNDER § 12–102 OF THE HEALTH OCCUPATIONS ARTICLE IF THE ENTITY  22 
DETERMINES THAT : 23 
 
  (1) THE PROVIDER THAT AD MINISTERS OR DISPENS ES THE COVERED 24 
SPECIALTY DRUG : 25 
 
   (I) IS AN IN –NETWORK PROVIDER OF COVERED MEDICAL  26 
ONCOLOGY SERVICES ; AND  27 
 
   (II) COMPLIES WITH STATE REGULATIONS FOR  THE 28 
ADMINISTERING AND DI SPENSING OF SPECIALT Y DRUGS ; AND 29 
 
  (2) THE COVERED SPECIALT Y DRUG IS : 30 
 
   (I) INFUSED , AUTO–INJECTED , OR AN ORAL TARGETED 31 
IMMUNE MODULATOR ; OR 32 
4 SENATE BILL 975   
 
  
   (II) AN ORAL ME DICATION THAT : 1 
 
    1. REQUIRES COMPLEX DOS ING BASED ON CLINICA L 2 
PRESENTATION ; OR 3 
 
    2. IS USED CONCOMITANTL Y WITH OTHER INFUSIO N OR 4 
RADIATION THERAPIES . 5 
 
 (D) (1) THE SUBJECT TO SUBSECTION  (F) OF THIS SECTION , THE 6 
REIMBURSEMENT RATE F OR SPECIALTY DRUGS COVERED UNDER THIS S ECTION 7 
SHALL BE : 8 
 
  (1) (I) AGREED TO BY THE COV ERED , IN–NETWORK PROVIDER AND  9 
THE ENTITY SUBJECT T O THIS SECTION ; AND  10 
 
  (2) (II) BILLED AT A NONHOSPI TAL LEVEL OF CARE OR  PLACE OF 11 
SERVICE . 12 
 
  (2) UNLESS OTHERWISE AGRE ED TO BY THE COVERED , IN–NETWORK 13 
PROVIDER AND THE ENT ITY SUBJECT TO THIS SECTION , THE REIMBURSEMENT RA TE 14 
FOR SPECIALTY DRUGS COVERED UNDER THIS S ECTION MAY NOT EXCEE D THE RATE 15 
APPLICABLE TO A DESI GNATED SPECIALTY PHA RMACY FOR DISPENSING  THE 16 
COVERED SPECIALTY DR UGS. 17 
 
 (E) THIS SECTION DOES NOT  PROHIBIT AN ENTITY S UBJECT TO THIS 18 
SECTION FROM REFUSIN G TO AUTHORIZE OR AP PROVE OR FROM DENYIN G 19 
COVERAGE FOR A COVER ED SPECIALTY DRUG AD MINISTERED OR DISPEN SED BY A 20 
PROVIDER IF ADMINIST ERING OR DISPENSING THE DRUG FAILS TO SA TISFY  21 
MEDICAL NECESSITY CR ITERIA . 22 
 
 (F) THIS SECTION MAY NOT BE CONSTRUED TO SUPE RSEDE THE AUTHORITY 23 
OF THE HEALTH SERVICES COST REVIEW COMMISSION TO SET RAT ES FOR 24 
SPECIALTY DRUGS ADMI NISTERED TO PATIENTS  IN A SETTING REGULAT ED BY THE 25 
HEALTH SERVICES COST REVIE W COMMISSION . 26 
 
15–1611.1.  27 
 
 (a) This section applies only to a pharmacy benefits manager that provides 28 
pharmacy benefits management services on behalf of a carrier.  29 
 
 (b) Except as provided in subsection (c) of this section, a pharmacy benefits 30 
manager may  not require that a beneficiary use a specific pharmacy or entity to fill a 31 
prescription if:  32 
 
 SENATE BILL 975  5 
 
   (1) the pharmacy benefits manager or a corporate affiliate of the pharmacy 1 
benefits manager has an ownership interest in the pharmacy or entity; or  2 
 
  (2) the p harmacy or entity has an ownership interest in the pharmacy 3 
benefits manager or a corporate affiliate of the pharmacy benefits manager.  4 
 
 (c) [A] EXCEPT AS PROVIDED IN  § 15–847.2  OF THIS TITLE , A pharmacy 5 
benefits manager may require a beneficiary to use a specific pharmacy or entity for a 6 
specialty drug as defined in § 15 –847 of this title.  7 
 
15–1612.  8 
 
 (a) This section applies only to a pharmacy benefits manager that provides 9 
pharmacy benefits ma nagement services on behalf of a carrier.  10 
 
 (b) This section does not apply to reimbursement:  11 
 
  (1) EXCEPT AS PROVIDED I N § 15–847.2  OF THIS TITLE , for specialty 12 
drugs;  13 
 
  (2) for mail order drugs; or  14 
 
  (3) to a chain pharmacy with more than 15 stores or  a pharmacist who is 15 
an employee of the chain pharmacy.  16 
 
 (c) A pharmacy benefits manager may not reimburse a pharmacy or pharmacist 17 
for a pharmaceutical product or pharmacist service in an amount less than the amount that 18 
the pharmacy benefits manager rei mburses itself or an affiliate for providing the same 19 
product or service.  20 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 21 
policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 22 
after January 1, 2026.  23 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 24 
January 1, 2026.  25 
 